Terms: = Sarcomas AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12
152 results:
1. CD30 expression in an emerging group of mesenchymal spindle cell neoplasms with ALK fusion detected by flow cytometry and immunohistochemistry.
Iwakoshi A; Kikui H; Nakashima R; Goto Y; Ichikawa D; Sasaki E; Sekimizu M; Hattori H; Maeda N
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23228. PubMed ID: 38380728
[TBL] [Abstract] [Full Text] [Related]
2. Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions.
Rosell R; Pedraz-Valdunciel C; Jain A; Shivamallu C; Aguilar A
Expert Opin Investig Drugs; 2024 Mar; 33(3):171-182. PubMed ID: 38372666
[TBL] [Abstract] [Full Text] [Related]
3. Novel KMT2B gene mutation in MUC4 positive low-grade fibromyxoid sarcoma.
Zhang L; Luo L; Liu C; Li Z
Diagn Pathol; 2024 Feb; 19(1):30. PubMed ID: 38347522
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations.
Klubíčková N; Dermawan JK; Mosaieby E; Martínek P; Vaněček T; Hájková V; Ptáková N; Grossmann P; Šteiner P; Švajdler M; Kinkor Z; Michalová K; Szepe P; Plank L; Hederová S; Kolenová A; Spasov NJ; Kosemehmetoglu K; Pažanin L; Špůrková Z; Baník M; Baumruk L; Meyer A; Kalmykova A; Koshyk O; Michal M; Michal M
J Pathol; 2024 May; 263(1):61-73. PubMed ID: 38332737
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Pallocca M; Molineris I; Berrino E; Marcozzi B; Betti M; Levati L; D'Atri S; Menin C; Madonna G; Ghiorzo P; Bulgarelli J; Ferraresi V; Venesio T; Rodolfo M; Rivoltini L; Lanfrancone L; Ascierto PA; Mazzarella L; Pelicci PG; De Maria R; Ciliberto G; Medico E; Russo G
J Transl Med; 2024 Jan; 22(1):29. PubMed ID: 38184610
[TBL] [Abstract] [Full Text] [Related]
6. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
7. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
[TBL] [Abstract] [Full Text] [Related]
8. Usefulness of an RNA extraction-free test for the multiplexed detection of
Damiola F; Alberti L; Mansuet-Lupo A; Damotte D; Hofman V; Tixier L; Penault-Llorca F; Rouquette I; Vignaud JM; Cazes A; Forest F; Begueret H; Gibault L; Badoual C; Cayre A; Taranchon-Clermont E; Duc A; Mc Leer A; Lantuejoul S
Expert Rev Mol Diagn; 2023; 23(12):1283-1291. PubMed ID: 37906110
[TBL] [Abstract] [Full Text] [Related]
9. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
[TBL] [Abstract] [Full Text] [Related]
10. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
[TBL] [Abstract] [Full Text] [Related]
11. Cost-Efficient Detection of
Romanko AA; Mulkidjan RS; Tiurin VI; Saitova ES; Preobrazhenskaya EV; Krivosheyeva EA; Mitiushkina NV; Shestakova AD; Belogubova EV; Ivantsov AO; Iyevleva AG; Imyanitov EN
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762506
[TBL] [Abstract] [Full Text] [Related]
12. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy.
Nakano K
Jpn J Clin Oncol; 2023 Oct; 53(10):885-892. PubMed ID: 37394916
[TBL] [Abstract] [Full Text] [Related]
13. FDA Approval Summary: Selpercatinib for the Treatment of Advanced ret Fusion-Positive Solid Tumors.
Duke ES; Bradford D; Marcovitz M; Amatya AK; Mishra-Kalyani PS; Nguyen E; Price LSL; Fourie Zirkelbach J; Li Y; Bi Y; Kraft J; Dorff SE; Scepura B; Stephenson M; Ojofeitimi I; Nair A; Han Y; Tezak Z; Lemery SJ; Pazdur R; Larkins E; Singh H
Clin Cancer Res; 2023 Sep; 29(18):3573-3578. PubMed ID: 37265412
[TBL] [Abstract] [Full Text] [Related]
14. Pathological characteristics and tumour immune microenvironment of lung malignancies with ret rearrangement.
Gao QY; Xiao FM; Lin XC; Chen YQ; Li YF; Lu C; Su JW; Tan QQ; Zhang CY; Yang J; Wu YL; Chen HJ; Yang JJ
Cancer Treat Res Commun; 2023; 35():100707. PubMed ID: 37121144
[TBL] [Abstract] [Full Text] [Related]
15. Resistance and endurance exercise training improves muscle mass and the inflammatory/fibrotic transcriptome in a rhabdomyosarcoma model.
Collao N; Sanders O; Caminiti T; Messeiller L; De Lisio M
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):781-793. PubMed ID: 36797054
[TBL] [Abstract] [Full Text] [Related]
16. Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or ret Fusions.
Kojima N; Mori T; Motoi T; Kobayashi E; Yoshida M; Yatabe Y; Ichikawa H; Kawai A; Yonemori K; Antonescu CR; Yoshida A
Mod Pathol; 2023 Apr; 36(4):100083. PubMed ID: 36788089
[TBL] [Abstract] [Full Text] [Related]
17. Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.
Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36744987
[TBL] [Abstract] [Full Text] [Related]
18. Blood Liquid Biopsy in an Advanced Medullary Thyroid Carcinoma: A Case Study with Rearranged during Transfection Heterogeneity.
Gumà J; Peña KB; Riu F; Lucia-Gozálvez C; Vidaller A; Maldonado V; Parada D
Pathobiology; 2023; 90(4):281-288. PubMed ID: 36731433
[TBL] [Abstract] [Full Text] [Related]
19. Head and Neck Mesenchymal Tumors with Kinase Fusions: A Report of 15 Cases With Emphasis on Wide Anatomic Distribution and Diverse Histologic Appearance.
Xu B; Suurmeijer AJH; Agaram NP; Antonescu CR
Am J Surg Pathol; 2023 Feb; 47(2):248-258. PubMed ID: 36638315
[TBL] [Abstract] [Full Text] [Related]
20. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract] [Full Text] [Related]
[Next]
